Comparison Chart Cytokinetics, Incorporated
Stocks
CYTK
US23282W6057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.11 USD | -1.33% |
|
-6.79% | +24.50% |
| 07-14 | Cytokinetics Insider Sold Shares Worth $615,150, According to a Recent SEC Filing | MT |
| 07-07 | RBC Capital Adjusts Cytokinetics Price Target to $117 From $119, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYTOKINETICS, INCORPORATED | Bio Therapeutic Drugs | -1.33% | -6.79% | +24.50% | +112.49% | +193.00% | 10.89B |  | | |
- Stock Market
- Stocks
- CYTK Stock
- Charts Cytokinetics, Incorporated
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition